The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Trial on Safety and Pharmacokinetics of Intravaginal Curcumin
Official Title: Phase I Trial on Safety and Pharmacokinetics of Intravaginal Curcumin in Normal Female Subjects
Study ID: NCT01035580
Brief Summary: The main objective of this study is to determine the maximum tolerable dose and safety of intravaginal curcumin in a normal population of women (women with no evidence of cervical cytological abnormalities by pap testing).
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT
Sex: FEMALE
Healthy Volunteers: Yes
Emory University, Atlanta, Georgia, United States
Name: Lisa Flowers, Medical
Affiliation: Emory University
Role: PRINCIPAL_INVESTIGATOR